NUS ranked second, NTU 11th among Asian universities

NUS ranked second, NTU 11th among Asian universities

The National University of Singapore (NUS) retained its second position while the Nanyang Technological University (NTU) came in 11th in the latest Asia University Rankings by the Times Higher Education (THE) magazine released on Thursday (June 19).

The NUS and NTU both maintained their 2013 position in the top 100 universities ranking list, which identifies the best universities in Asia including Turkey and the Middle East.

According to THE’s website, the ranking takes into account 13 separate performance indicators covering all the core missions of the modern globally focused university - research, teaching, knowledge transfer and international activity.

NUS President Tan Chorh Chuan said of the results: “This is an affirmation of NUS’ strong international reputation, and a recognition of the University’s quality education and world-class research. We will continue to innovate to deliver world-class education with both a global and Asian perspective, and to spearhead groundbreaking research that will benefit Singapore, Asia and beyond.”

Mr Phil Baty, Editor of the Times Higher Education Ranking, said the latest ranking confirms NUS as a “truly outstanding institution”.

“What is more, NUS has been consistently moving up the overall World University Rankings, which suggests that it is poised, one day, to become Asia’s undisputed number one university,” he added.

NUS was ranked 26th in the latest World University Rankings, behind The University of Tokyo in 23rd place. Singapore’s other university, Nanyang Technological University (NTU), came in at 76th, according to the rankings.

~News courtesy of Channel Newsasia~

New treatment for glaucoma unveiled

New treatment for glaucoma unveiled

A new treatment for glaucoma may mean that patients can do away with the use of daily eye drops.

Unveiled on Tuesday (June 3), the treatment involves a painless injection to the front of the eye which delivers millions of nano-sized capsules – thousands of times smaller than a speck of dust – that release anti-glaucoma drugs slowly over six months.

Glaucoma is a condition that causes damage to the eye's optic nerve and could lead to blindness.

Jointly developed by scientists from Nanyang Technological University (NTU) and the Singapore Eye Research Institute, the new therapy has undergone a pilot study with six patients. Researchers said it has yielded exceptional results, and has been both safe and effective in the treatment of glaucoma.

The new nanomedicine is also expected to benefit the elderly, who often forget to use the daily eye drops, leading to their conditions worsening.

The researchers estimated that at least 10 per cent of blindness from glaucoma is directly caused by patients not adhering correctly to prescribed medications.

~News courtesy of Channel Newsasia~